1 资料与方法
1.1 病例选择
1.2 定义及分组
1.3 观察指标
1.4 统计学分析
2 结果
表1 两组患者一般临床资料比较Table 1 Comparison of general clinical characteristics between the two groups |
| Items | Non-radiographic bone erosion (n=41) | No bone erosion detected (n=82) | P |
| Age/years | 48 (33, 54) | 49 (33, 53) | 0.180 |
| Gender | 0.999 | ||
| Male | 40 (97.6) | 80 (97.6) | |
| Female | 1 (2.4) | 2 (2.4) | |
| BMI/ (kg/m2) | 27.7 (23.4, 29.4) | 27.3 (24.8, 30.1) | 0.674 |
| Disease duration/years | 6.0 (3.0, 10.0) | 3.0 (0.9, 6.0) | 0.020 |
| Somking | 20 (48.8) | 44 (53.7) | 0.006 |
| Drinking | 19 (46.3) | 31 (37.8) | 0.272 |
| Family history | 8 (19.5) | 12 (14.6) | 0.002 |
Data were M(P25, P75) or n (%). BMI, body mass index. |
表2 两组患者痛风累及关节比较Table 2 Comparison of gout-involved joints between the two groups |
| Items | Non-radiographic bone erosion (n=41) | No bone erosion detected (n=82) | P |
| Involved joint count | 5 (2, 8) | 3 (2, 4) | 0.020 |
| Flare counts per year≥3 | 31 (75.6) | 39 (47.6) | <0.001 |
| Foot joint involvement | 36 (87.8) | 61 (74.4) | <0.001 |
| Ankle involvement | 25 (61.0) | 54 (65.9) | <0.001 |
| Knee involvement | 23 (56.1) | 45 (54.9) | 0.001 |
| Hand joint involvement | 17 (41.5) | 16 (19.5) | 0.268 |
| Elbow involvement | 7 (17.1) | 7 (8.5) | <0.227 |
| Tophi | 7 (17.1) | 7 (8.5) | <0.227 |
Data were n (%). |
表3 两组患者实验室指标比较Table 3 Comparison of laboratory indicators between the two groups |
| Items | Non-radiographic bone erosion (n=41) | No bone erosion detected (n=82) | P |
| UA /(μmol/L) | 498.9±146.6 | 538.4±141.0 | 0.282 |
| GLU/ (μmol/L) | 5.2 (4.9, 5.7) | 5.3 (4.9, 5.7) | 0.854 |
| CHOL/(mmol/L) | 4.8±1.0 | 4.9±1.1 | 0.898 |
| TG/(mmol/L) | 1.6 (1.3, 2.3) | 1.9 (1.2, 2.8) | 0.928 |
| LDL/(mmol/L) | 3 (2.6, 3.6) | 3.3 (2.4, 3.8) | 0.604 |
| HDL/(mmol/L) | 1.2±0.3 | 1.2±0.3 | 0.341 |
| Cr/(μmol/L) | 83 (74, 96) | 81 (71, 94) | 0.995 |
| HCY/(μmol/L) | 17.1 (13.2, 22.4) | 17.1 (13.3, 24.8) | 0.456 |
| WBC/(×109/L) | 8.1 (5.9, 10.4) | 8.3 (7.0, 10.4) | 0.496 |
| pH | 5.9 (5.5, 6.5) | 5.5 (5.5, 6.0) | 0.850 |
Data were ${\bar x}$±s or M(P25, P75). UA, uric acid; GLU, glucose; CHOL, cholesterol; TG, triglyceride; LDL, low-density lipoprotein; HDL, high-density lipoprotein; Cr, creatinine; HCY, homocysteine; WBC, white blood counts. |
表4 两组患者合并症比较Table 4 Comparison of comorbidities between the two groups |
| Items | Non-radiographic bone erosion (n=41) | No bone erosion detected (n=82) | P |
| Hypertension | 21 (51.2) | 45 (54.9) | 0.003 |
| Diabetes mellitus | 3 (7.3) | 11 (13.4) | 0.382 |
| Cardiovascular disease | 1 (2.4) | 2 (2.4) | 0.999 |
| Renal calculi | 5 (12.2) | 12 (14.6) | 0.001 |
Data were n (%). |
表5 痛风患者放射学阴性骨侵蚀的相关多因素分析Table 5 Multivariate analysis of factors associated with non-radiographic bone erosion in gout patients |
| Variable | B | SE | Wald | df | P | OR (95%CI) |
| Disease duration | 0.085 | 0.054 | 2.448 | 1 | 0.118 | 1.088 (0.979-1.210) |
| Somking | 0.113 | 0.472 | 0.057 | 1 | 0.811 | 1.119 (0.444-2.825) |
| Family history | 0.406 | 0.597 | 0.462 | 1 | 0.497 | 1.501 (0.466-4.835) |
| Involved joint count | 0.042 | 0.101 | 0.173 | 1 | 0.677 | 1.043 (0.855-1.272) |
| Flare counts per year≥3 | 1.637 | 0.618 | 7.006 | 1 | 0.008 | 5.139 (1.529-17.271) |
| Foot joint involvement | 0.403 | 0.692 | 0.340 | 1 | 0.560 | 1.497 (0.386-5.807) |
| Ankle involvement | -0.867 | 0.603 | 2.066 | 1 | 0.151 | 0.420 (0.129-1.371) |
| Knee involvement | -0.334 | 0.557 | 0.360 | 1 | 0.549 | 0.716 (0.240-2.133) |
| Hypertension | -0.211 | 0.481 | 0.191 | 1 | 0.662 | 0.810 (0.315-2.081) |
| Renal calculi | -0.670 | 0.712 | 0.885 | 1 | 0.347 | 0.512 (0.127-2.066) |